Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Oestrogen receptor assay. False positive analysis?

H S Poulsen, A Bukh, L Rytter

    Acta Radiologica. Oncology
    |January 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Report of the sixth Nordic Family Health and Care Conference 2024: Sharing Interdisciplinary Work to Improve the Health and Well-Being of Families.

    Journal of family nursing·2024
    Same author

    Validation of the type 1 diabetes distress scale (T1-DDS) in a large Danish cohort: Content validation and psychometric properties.

    Heliyon·2023
    Same author

    Spiral and target wave chimeras in a 2D lattice of map-based neuron models.

    Chaos (Woodbury, N.Y.)·2019
    Same author

    Asymptomatic hypoglycaemia in Type 1 diabetes: incidence and risk factors.

    Diabetic medicine : a journal of the British Diabetic Association·2018
    Same author

    Toxicity and efficacy of lomustine and bevacizumab in recurrent glioblastoma patients.

    Journal of neuro-oncology·2018
    Same author

    Prognostic value of O-6-methylguanine-DNA methyltransferase (MGMT) protein expression in glioblastoma excluding nontumour cells from the analysis.

    Neuropathology and applied neurobiology·2017

    This study investigated how different hormones affect estrogen receptor binding in breast cancer. Some patients showed unique binding patterns involving testosterone and other steroids, suggesting novel therapeutic targets.

    Area of Science:

    • Endocrinology
    • Oncology
    • Molecular Biology

    Background:

    • Estrogen receptors (ER) play a crucial role in the development and progression of primary breast carcinoma.
    • Understanding the binding characteristics of ER is essential for developing targeted therapies.

    Purpose of the Study:

    • To investigate the influence of unlabeled hormones, including estradiol, diethylstilbestrol (DES), testosterone, and R-5020/org 2058, on tritiated estradiol binding in ER-positive breast cancer.
    • To identify distinct patterns of hormone binding to ER in a cohort of primary breast carcinoma patients.

    Main Methods:

    • Utilized dextran-coated charcoal and sucrose gradient methods to assess hormone binding.
    • Analyzed binding displacement of tritiated estradiol by various unlabeled steroids in 162 ER-positive breast cancer cases.

    Related Experiment Videos

    Main Results:

    • In 122 cases (75%), only unlabeled estradiol and DES significantly displaced tritiated estradiol binding, consistent with known ER activity.
    • In 40 cases (25%), estradiol, DES, testosterone, and R-5020/org 2058 equally displaced high-affinity, saturable binding of tritiated estradiol.
    • This suggests a subset of ER-positive breast cancers exhibit altered steroid hormone binding profiles.

    Conclusions:

    • A significant proportion of ER-positive primary breast carcinomas display unusual hormone-binding characteristics.
    • The findings suggest that testosterone and synthetic progestins may interact with ER in ways not previously recognized in certain breast cancer subtypes.
    • Further research is warranted to explore the clinical implications and potential therapeutic strategies targeting these novel binding interactions.